Contineum Therapeutics, Inc. (CTNM) vs Entera Bio Ltd. (ENTX)

Contineum Therapeutics, Inc. and Entera Bio Ltd. are both Biotechnology companies. Contineum Therapeutics, Inc. and Entera Bio Ltd. are of similar size ($486.7M and $469.9M). Across the 9 metrics below, Contineum Therapeutics, Inc. leads on 5 and Entera Bio Ltd. on 4.

Valuation

Metric CTNM ENTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 622.15 11.47
P/B 1.96 19.09 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 540.72 10.73
Earnings yield (13.77%) (12.73%) (28.84%)
Free cash flow yield (11.36%) (7.92%) (23.03%)

Profitability

Metric CTNM ENTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (28.01%) (138.92%) (57.72%)
Return on assets (26.57%) (87.02%) (49.22%)
Return on invested capital (1,334.41%) 0.00% 0.00%

Growth

Metric CTNM ENTX Biotechnology median
Revenue growth (TTM) — 66.42% 5.64%
EPS growth (last fiscal year) 0.46% 0.00% —
Revenue growth, 5-year CAGR — (29.19%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTNM ENTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 37.17 8.98 4.73
Net debt to EBITDA 3.88 1.29 0.96

Dividend

Metric CTNM ENTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CTNM ENTX Biotechnology median
Market cap 469.89m 486.74m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack